Science Explorer Interactive view Map
Company · San Carlos · United States

Cellerant Therapeutics (United States)

cellerant.comROR OpenAlex
Research works
32
▼ 23% vs 2013–17
Citations
1.1k
35.2 per fractional work
Top-10% rate
5.4%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Cellerant Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 7.75× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 1.00× its world share, 0 worksImmunology and Micro…Chemistry: 3.21× its world share, 0 worksChemistryEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 0 worksMaterials ScienceDentistry: 0.62× its world share, 0 worksDentistryHealth Professions: 0.13× its world share, 0 worksHealth ProfessionsMedicine: 2.66× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.8×. Every wedge is a field page.

Which keywords describe research at Cellerant Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Inflammation, Mesenchymal Stem Cells, Glycosylation, Chemotherapy, Tumor Microenvironment, Immunotherapy and Hematopoietic Stem Cells.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Cancer4▲ 8.9×9 topics
  2. Inflammation4▲ 5.4×16 topics
  3. Mesenchymal Stem Cells2▲ 59×3 topics
  4. Chemotherapy2▲ 9.1×8 topics
  5. Glycosylation2▲ 30×2 topics
  6. Oxidative Stress2▲ 3.6×10 topics
  7. Tumor Microenvironment2▲ 18×4 topics
  8. Immunotherapy2▲ 8.8×5 topics
  9. Hematopoietic Stem Cells2▲ 54×2 topics
  10. Toll-like Receptors2▲ 29×3 topics
  11. Genomic Instability2▲ 37×2 topics
  12. Monoclonal Antibodies1▲ 31×2 topics
  13. Bone Marrow Niche1▲ 119×1 topic
  14. Fc Receptors1▲ 42×1 topic
  15. Graft-versus-Host Disease1▲ 119×1 topic
  16. HIF-11▲ 56×1 topic
  17. Hemostasis1▲ 28×4 topics
  18. Metabolism1▲ 6.3×4 topics
  19. Regeneration1▲ 22×3 topics
  20. Therapeutic Antibodies1▲ 33×1 topic
  21. Warburg Effect1▲ 56×1 topic
  22. Angiogenesis1▲ 9.0×5 topics
  23. Cancer Immunotherapy1▲ 26×2 topics
  24. Drug Discovery1▲ 9.6×4 topics
  25. Gene Therapy1▲ 14×3 topics
  26. Immunity1▲ 11×2 topics
  27. Microfluidics1▲ 39×1 topic
  28. Particle Separation1▲ 95×1 topic
  29. Tumor Regression1▲ 40×2 topics
  30. Prophylaxis1▲ 23×2 topics
  31. Radiotherapy1▲ 8.5×4 topics

Which research topics does Cellerant Therapeutics (United States) publish most on?

By volume in 2022–2025: DNA Repair Mechanisms, Venomous Animal Envenomation and Studies, Monoclonal and Polyclonal Antibodies Research and Blood Coagulation and Thrombosis Mechanisms.

DNA Repair Mechanisms1DNA Repair Mechanisms: 1 fractional worksVenomous Animal Envenomation and Studies: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksBlood Coagulation and Thrombosis Mechanisms: 0 fractional worksHIV/AIDS drug development and treatment: 0 fractional worksEffects of Radiation Exposure: 0 fractional worksBiochemical and Molecula…0Biochemical and Molecular Research: 0 fractional worksChemotherapy-induced cardiotoxicity and mitigation: 0 fractional worksMitochondrial Function and Pathology: 0 fractional worksProstate Cancer Diagnosi…0Prostate Cancer Diagnosis and Treatment: 0 fractional works
Molecular BiologyGeneticsRadiology, Nuclear Medicine and ImagingHematology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 DNA Repair Mechanisms Molecular Biology 1 works
  2. 2 Venomous Animal Envenomation and Studies Genetics 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
  5. 5 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  6. 6 Effects of Radiation Exposure Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Biochemical and Molecular Research Molecular Biology 0 works
  8. 8 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
  9. 9 Mitochondrial Function and Pathology Molecular Biology 0 works
  10. 10 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.5%not open48.5%

World: 28% of research is openly available.

with international co-authors12.8%domestic only87.2%

World: 19% is written across borders.

How has Cellerant Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 23% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Carlos

All research institutions in San Carlos

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.